Physician profile
Maria Munoz
NPI 1215964929
$842.65
in general payments reported to CMS, 2019-2025
9 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.15 · 2020: $28.43 · 2021: $87.80 · 2022: $66.66 · 2023: $176 · 2024: $212 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $306.49 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $228.34 | 2019-2024 | Vaxelis, Vaqta, Gardasil 9 |
| Pfizer INC. | $170.85 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $43.84 | 2025 | Daybue |
| Glaxosmithkline, LLC. | $33.92 | 2023-2024 | Pediarix, Bexsero, Rotarix |
| Lupin INC. | $16.92 | 2019 | |
| Seqirus USA INC | $16.86 | 2025 | Flucelvax, Fluad |
| Takeda Pharmaceuticals U.S.A., INC. | $13.71 | 2021 | |
| Genentech USA, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.